Reforming L forms: they need part of a wall after all?
Young
Kevin D
KD
Department of Microbiology and Immunology, University of North Dakota School of Medicine, Grand Forks, ND 58202, USA. kyoung@medicine.nodak.edu
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002441:Cefsulodin / Q000494:pharmacology; D002473:Cell Wall / Q000378:metabolism*; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development*; D007740:L Forms / Q000187:drug effects / Q000254:growth & development*; D010457:Peptidoglycan / Q000096:biosynthesis* / Q000737:chemistry
D000900:Anti-Bacterial Agents; D010457:Peptidoglycan; D002441:Cefsulodin